A divided Supreme Court on Thursday shielded generic drug makers from consumer lawsuits alleging they inadequately labeled their products. The 5-4 ruling, written by Justice Clarence Thomas...
Citigroup Inc. (C) has paid a $130,000 fine to the state of Texas for failing to report complaints and arbitration claims against a sales agent who had a history of complaints. The banking giant...
Sen. Herb Kohl (D., Wisc.) is pressing pharmaceutical companies such as GlaxoSmithKline PLC (GSK, GSK.LN), Eli Lilly & Co. (LLY) and Pfizer Inc. (PFE) to explain why their drugs often cost...
Sen. Herb Kohl (D., Wisc.) is pressing pharmaceutical companies such as GlaxoSmithKline PLC (GSK, GSK.LN), Eli Lilly & Co. (LLY) and Pfizer Inc. (PFE) to explain why their drugs often cost...
About half the pharmaceutical industry's growth is expected to come from emerging markets by 2013, with China taking the place of France as the world's third-largest market by as soon as next...
NEW YORK, Feb. 22 /PRNewswire/ -- S&P MidCap 400 constituent Helmerich & Payne Inc. (NYSE:HP) will replace IMS Health Inc. (NYSE:RX) in the S&P 500 index, S&P SmallCap 600 constituent Prosperity...
IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that it expects to close the merger...
IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend...
IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced fourth-quarter 2009 revenue of $599.2...
IMS Health (NYSE: RX), the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced that its stockholders approved the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.